Micha Breakstone

Micha Breakstone is a seasoned entrepreneur and investor specializing in early-stage technology ventures, particularly in AI and biotech sectors. He co-founded Chorus.ai, a conversation intelligence company acquired by ZoomInfo for $575 million, and NeuraLight, an AI-driven platform for neurological disorders. In 2023, he co-founded Somite.ai, focusing on AI-driven cell therapies, securing a $47 million Series A round led by Khosla Ventures. Micha has mentored over 130 Israeli startups and invested in 32, contributing to the growth of several AI Israeli unicorns. He holds an MSc in Mathematics and a PhD in Cognitive Science from The Hebrew University of Jerusalem. Micha is based in Austin, Texas, and continues to support early-stage technology ventures through his investments and mentorship.

Through his entrepreneurial ventures, mentorship, and investments, Micha Breakstone has significantly contributed to the growth and success of the Israeli tech ecosystem and beyond, with his latest venture promising revolutionary advances in healthcare. His commitment to nurturing the next generation of tech innovation is evident in his active involvement in the startup community, both in Israel and the United States. Micha's broad experience in designing Machine Learning systems is underpinned by a strong academic foundation, holding a Master's in Mathematics and a Ph.D. in Cognitive Science.

Micha's dedication to advancing the field of AI and biotechnology is further demonstrated by his leadership roles in companies like NeuraLight and Somite.ai. His strategic vision and ability to attract significant investment have been instrumental in driving innovation and growth in these sectors. As a mentor and advisor, Micha continues to play a pivotal role in shaping the future of technology and healthcare, leveraging his expertise to guide and support emerging startups. His ongoing efforts reflect a deep commitment to fostering innovation and excellence in the tech industry.